This report shows public data only. Is this your organisation? If so, login here to view your full report.

Lyxor Asset Management

PRI reporting framework 2020

Export Public Responses
Pdf-img

You are in Confidence building measures » Confidence building measures

信頼醸成措置

CM1 01. Assurance, verification, or review

01.1. 本年度のPRI 透明性レポート を対象に提供いただく報告情報が以下項目にある各プロセスを経たものであるかどうかを明示してください:

01.2. 補足情報 [任意]

          The process of creating the United Nations Principles for Responsible Investment (UN PRI) Transparency Report 2019 ensures the completeness and accuracy of reported information and timeliness of reporting. 

1/ A SRI analyst (in charge of the regulatory and reporting issues) part of the LYXOR SRI team is in charge to complete the whole questionnaire and documents the reporting process.
She ensures the completeness and accuracy of collected information and timeliness of reporting.


2/ First review : each SRI analyst, part of the SRI team, review one or severale modules assigned 
- The Active Ownership & Engagement specialist review the LEA and FI Modules related to engagement & proxy voting
- The SRI Analyst specialized in ESG integration review all ESG integration specific modules ( SG, LEI & FI )

The internal review approach consisted of the following activities: 
• Reviews with LYXOR employees involved; 
• Review of relevant documents, such as the UN PRI Transparency Report, PRI assessment, overview of questions and related evidence.

3/ Final review by the Head of SRI team
During this review, the accuracy and completeness of answers given were appropriately challenged and checked using the related source documentation.

4/ third party insurance
LYXOR adheres to an RI labelling scheme for some of its sustainable product
At group level, the registration document (chapter five) which contains information related to Lyxor and its SRI Policy has been audited by a third party.
        

CM1 02. Assurance of last year`s PRI data

02.1. 昨年度のPRI 透明性レポートに関しては、第三者による独立した保証を取り付けている

02.3. 補足情報 [任意]

          
        

CM1 03. Other confidence building measures

03.1. PRI 透明性レポートに含まれているデータに限定せず、信頼醸成措置を定めている。:

03.2. どのスキームですか?

スキームが適用される資産の総AUMに占める割合

具体的に記入してください

          The French energy and ecological transition for the climate label : GREENFIN Label
https://www.ecologique-solidaire.gouv.fr/label-transition-energetique-et-ecologique-climat
        

スキームが適用される資産の総AUMに占める割合

          At group level , the registration document (chapter five) which contains information related to Lyxor and its SRI Policy has been audited by a third party.
        

03.5. 補足情報 [任意]

          
        

CM1 04. Assurance of this year`s PRI data (Not Applicable)


CM1 05. External assurance

05.1. 本年度のPRI透明性レポート から選択された回答に対する、または、本年度の PRIへの回答にその後使用された他のソースからのデータポイントに対する、第三者保証について、詳細を提供してください。

保証の対象となるデータ

関連モジュール

保証を行った者

          For French SRI label : Ernst & Young. For GREENFIN label : Novethic 
Information related to Lyxor and its SRI Policy has been audited by Ernst & Young
        

使用した保証基準

具体的に記入してください

          the registration document (chapter five) which contains information related to Lyxor and its SRI Policy has been audited by a third party.
        

目指した保証レベル

以下を記載してください

外部保証提供者の報告書へのリンク先 https://www.ecologique-solidaire.gouv.fr/label-greenfin
元データ・ソースのリンク先(公表データの場合) https://www.lyxor.com/cplabel-isrlyxor-etffinal-fr

Attach a file


05.2. 補足情報 [任意]

          LYXOR adheres to an RI labeling scheme for some of its sustainable products. 
In the context of these labelings, all investment process, criteria, selection process,... have been reviewed by external auditors (Ernst & Young for French SRI label, and  Novethic for the French GREENFIN label)
At group level, the registration document (chapter five) which contains information related to Lyxor and its SRI Policy has been audited by a third party. Ernst & Young issued a notice that contains a moderate insurance.
        

CM1 06. Assurance or internal audit (Not Applicable)


CM1 07. Internal verification

07.1. PRI透明性レポート 全体(またはその中から選択されたデータ)を内部で見直した、または検証した者を示し、選択されたデータにこれが適用される場合には、どのデータを見直したか具体的に記入してください。

検証実施者

07.2. 補足情報 [任意]

          
        

Top